Demant AS Unsponsored ADR (WILYY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks ...

Investors in Demant A/S (CPH:DEMANT) had a good week, as its shares rose 2.2% to close at ø228 following the release of its yearly results. It looks like the results were a bit of a negative ...

Demant provided 2025 guidance, projecting organic revenue growth of 3%-7% and EBIT before special items in the range of ...

Narrow-moat Demant DEMANT announced that the U.K. Competition and Markets Authority’s provisional finding (prior to the final report in early June) is that the divestment of Oticon Medical to ...

Investing.com -- Shares of Demant A/S (CSE:DEMANT) fell 5.5% as the company reported a soft revenue dynamic, despite a 4% ...

Demant benefits from favourable trends, including an ageing population, increasing noise pollution, fairly low penetration rates in the developed world, and virtually untapped patient populations ...

In 2021, Demant reported revenues of 512 million Danish kroner, or about $72 million, for its hearing implant business. That’s less than 3% of the company’s entire revenue for the year, which ...

Demant provided 2025 guidance, projecting organic revenue growth of 3%-7% and EBIT before special items in the range of DKK4.5 billion to DKK4.9 billion.